Anticoagulant management in patients with atrial fibrillation.
Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with a high risk of embolic stroke (cause in 15% of all strokes and 30% of strokes in those >75 years of age). Anticoagulation with warfarin will reduce stroke risk by about two thirds. The main risks of anticoag...
| Main Authors: | , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2009
|
| _version_ | 1797096525130629120 |
|---|---|
| author | Fitzmaurice, D Hobbs, F |
| author_facet | Fitzmaurice, D Hobbs, F |
| author_sort | Fitzmaurice, D |
| collection | OXFORD |
| description | Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with a high risk of embolic stroke (cause in 15% of all strokes and 30% of strokes in those >75 years of age). Anticoagulation with warfarin will reduce stroke risk by about two thirds. The main risks of anticoagulation, namely bleeding, can be minimized by maintaining anticoagulation control within the international normalized range range of 2.0 to 3.0 (target: 2.5). To have a public health impact, patients with AF need efficient and correct identification, with appropriate treatment directed at those patients at most risk from the condition. |
| first_indexed | 2024-03-07T04:43:04Z |
| format | Journal article |
| id | oxford-uuid:d251e081-aec8-45ff-8a38-551bb464aa61 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T04:43:04Z |
| publishDate | 2009 |
| record_format | dspace |
| spelling | oxford-uuid:d251e081-aec8-45ff-8a38-551bb464aa612022-03-27T08:03:00ZAnticoagulant management in patients with atrial fibrillation.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:d251e081-aec8-45ff-8a38-551bb464aa61EnglishSymplectic Elements at Oxford2009Fitzmaurice, DHobbs, FAtrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with a high risk of embolic stroke (cause in 15% of all strokes and 30% of strokes in those >75 years of age). Anticoagulation with warfarin will reduce stroke risk by about two thirds. The main risks of anticoagulation, namely bleeding, can be minimized by maintaining anticoagulation control within the international normalized range range of 2.0 to 3.0 (target: 2.5). To have a public health impact, patients with AF need efficient and correct identification, with appropriate treatment directed at those patients at most risk from the condition. |
| spellingShingle | Fitzmaurice, D Hobbs, F Anticoagulant management in patients with atrial fibrillation. |
| title | Anticoagulant management in patients with atrial fibrillation. |
| title_full | Anticoagulant management in patients with atrial fibrillation. |
| title_fullStr | Anticoagulant management in patients with atrial fibrillation. |
| title_full_unstemmed | Anticoagulant management in patients with atrial fibrillation. |
| title_short | Anticoagulant management in patients with atrial fibrillation. |
| title_sort | anticoagulant management in patients with atrial fibrillation |
| work_keys_str_mv | AT fitzmauriced anticoagulantmanagementinpatientswithatrialfibrillation AT hobbsf anticoagulantmanagementinpatientswithatrialfibrillation |